BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26643900)

  • 1. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.
    Szenborn L; Kraszewska-Głomba B; Jackowska T; Duszczyk E; Majda-Stanisławska E; Marczyńska M; Ołdak E; Pawłowska M; Służewski W; Wysocki J; Stryczyńska-Kazubska J; Kuchar E
    J Infect Chemother; 2016 Feb; 22(2):65-71. PubMed ID: 26643900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
    König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
    Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for varicella and herpes zoster.
    Arvin AM
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients.
    Tayyar R; Ho D
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.
    Erard V; Guthrie KA; Varley C; Heugel J; Wald A; Flowers ME; Corey L; Boeckh M
    Blood; 2007 Oct; 110(8):3071-7. PubMed ID: 17515400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
    Vogt M; Huss R; Wunderli W
    Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management.
    Piret J; Boivin G
    Curr Opin Infect Dis; 2016 Dec; 29(6):654-662. PubMed ID: 27306564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy with acyclovir in infants and children.
    Arvin AM
    Pediatr Infect Dis J; 1987 Jan; 6(1):56-8. PubMed ID: 3029659
    [No Abstract]   [Full Text] [Related]  

  • 12. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Herpes virus infections in immunosuppressed patients. Herpes simplex and varicella zoster virus: prevention and therapy].
    Mertens T
    Fortschr Med; 1989 Aug; 107(25):537-40. PubMed ID: 2553562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
    Sáez-Llorens X; Yogev R; Arguedas A; Rodriguez A; Spigarelli MG; De León Castrejón T; Bomgaars L; Roberts M; Abrams B; Zhou W; Looby M; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2009 May; 53(5):1912-20. PubMed ID: 19273678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of alpha-herpes virus infections].
    Honda M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():306-10. PubMed ID: 16615489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of herpes simplex and varicella zoster infections in patients of HIV infections].
    Caumes E; Bricaire F
    Ann Med Interne (Paris); 1997; 148(3):255-7. PubMed ID: 9255335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.
    Pollack M; Heugel J; Xie H; Leisenring W; Storek J; Young JA; Kukreja M; Gress R; Tomblyn M; Boeckh M
    Biol Blood Marrow Transplant; 2011 May; 17(5):664-73. PubMed ID: 20699126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.